Garching / Munich, Germany, October 17, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced that post hoc subgroup analyses data from its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback